PL4223295T3 - Płynna kompozycja farmaceutyczna wykazująca doskonałą skuteczność konserwującą - Google Patents
Płynna kompozycja farmaceutyczna wykazująca doskonałą skuteczność konserwującąInfo
- Publication number
- PL4223295T3 PL4223295T3 PL21875535.3T PL21875535T PL4223295T3 PL 4223295 T3 PL4223295 T3 PL 4223295T3 PL 21875535 T PL21875535 T PL 21875535T PL 4223295 T3 PL4223295 T3 PL 4223295T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- excellent preservation
- demonstrating excellent
- preservation efficacy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020164034 | 2020-09-29 | ||
| PCT/JP2021/035417 WO2022071233A1 (ja) | 2020-09-29 | 2021-09-27 | 優れた保存効力を示す液状医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4223295T3 true PL4223295T3 (pl) | 2025-12-22 |
Family
ID=80949079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21875535.3T PL4223295T3 (pl) | 2020-09-29 | 2021-09-27 | Płynna kompozycja farmaceutyczna wykazująca doskonałą skuteczność konserwującą |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20230372315A1 (pl) |
| EP (1) | EP4223295B1 (pl) |
| JP (1) | JP7784623B2 (pl) |
| KR (1) | KR20230084205A (pl) |
| CN (1) | CN116472032A (pl) |
| AU (1) | AU2021354445A1 (pl) |
| BR (1) | BR112023005756A2 (pl) |
| CA (1) | CA3194011A1 (pl) |
| CL (1) | CL2023000871A1 (pl) |
| CO (1) | CO2023003536A2 (pl) |
| EC (1) | ECSP23020965A (pl) |
| ES (1) | ES3041708T3 (pl) |
| HR (1) | HRP20251100T1 (pl) |
| HU (1) | HUE073451T2 (pl) |
| MX (1) | MX2023003603A (pl) |
| PE (1) | PE20240109A1 (pl) |
| PL (1) | PL4223295T3 (pl) |
| RS (1) | RS67285B1 (pl) |
| SM (1) | SMT202500381T1 (pl) |
| TW (1) | TWI911294B (pl) |
| WO (1) | WO2022071233A1 (pl) |
| ZA (1) | ZA202303906B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3760200A4 (en) | 2018-03-01 | 2021-12-15 | Ishihara Sangyo Kaisha, Ltd. | PHARMACEUTICAL COMPOSITION WITH EXCELLENT STORAGE STABILITY |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0465913B1 (en) * | 1990-07-10 | 1997-09-10 | Ishihara Sangyo Kaisha, Ltd. | Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them |
| US6653333B2 (en) * | 2000-01-31 | 2003-11-25 | Ishihara Sangyo Kaisha, Ltd. | Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
| JP4848092B2 (ja) | 2000-02-01 | 2011-12-28 | 石原産業株式会社 | ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤 |
| EP1252891B1 (en) | 2000-02-01 | 2005-10-05 | Ishihara Sangyo Kaisha, Ltd. | Use of DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVES FOR the prevention and treatment of LIVER DISEASES |
| JP5584518B2 (ja) | 2009-05-28 | 2014-09-03 | 石原産業株式会社 | ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤 |
| BR112012003834A2 (pt) * | 2009-08-21 | 2017-08-08 | Targeted Delivery Tech Limited | métodos para tratamento de distúrbios e para tratamentos de deficiências em ácidos graxos, hipertrigliceridemia ou hipercolesterolemia e pacote |
| CN114949237A (zh) * | 2013-07-31 | 2022-08-30 | 斯昆申技术控股有限责任公司 | 囊泡 |
| EP3760200A4 (en) | 2018-03-01 | 2021-12-15 | Ishihara Sangyo Kaisha, Ltd. | PHARMACEUTICAL COMPOSITION WITH EXCELLENT STORAGE STABILITY |
-
2021
- 2021-09-27 AU AU2021354445A patent/AU2021354445A1/en active Pending
- 2021-09-27 BR BR112023005756A patent/BR112023005756A2/pt unknown
- 2021-09-27 PE PE2023001208A patent/PE20240109A1/es unknown
- 2021-09-27 KR KR1020237014639A patent/KR20230084205A/ko active Pending
- 2021-09-27 PL PL21875535.3T patent/PL4223295T3/pl unknown
- 2021-09-27 HR HRP20251100TT patent/HRP20251100T1/hr unknown
- 2021-09-27 CA CA3194011A patent/CA3194011A1/en active Pending
- 2021-09-27 SM SM20250381T patent/SMT202500381T1/it unknown
- 2021-09-27 CN CN202180066887.2A patent/CN116472032A/zh active Pending
- 2021-09-27 JP JP2022553959A patent/JP7784623B2/ja active Active
- 2021-09-27 HU HUE21875535A patent/HUE073451T2/hu unknown
- 2021-09-27 WO PCT/JP2021/035417 patent/WO2022071233A1/ja not_active Ceased
- 2021-09-27 RS RS20250959A patent/RS67285B1/sr unknown
- 2021-09-27 ES ES21875535T patent/ES3041708T3/es active Active
- 2021-09-27 EP EP21875535.3A patent/EP4223295B1/en active Active
- 2021-09-27 US US18/246,775 patent/US20230372315A1/en active Pending
- 2021-09-27 MX MX2023003603A patent/MX2023003603A/es unknown
- 2021-09-29 TW TW110136251A patent/TWI911294B/zh active
-
2023
- 2023-03-22 EC ECSENADI202320965A patent/ECSP23020965A/es unknown
- 2023-03-22 CO CONC2023/0003536A patent/CO2023003536A2/es unknown
- 2023-03-24 CL CL2023000871A patent/CL2023000871A1/es unknown
- 2023-03-28 ZA ZA2023/03906A patent/ZA202303906B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7784623B2 (ja) | 2025-12-12 |
| HRP20251100T1 (hr) | 2025-11-07 |
| RS67285B1 (sr) | 2025-11-28 |
| CL2023000871A1 (es) | 2023-11-10 |
| EP4223295A1 (en) | 2023-08-09 |
| CO2023003536A2 (es) | 2023-05-29 |
| MX2023003603A (es) | 2023-04-05 |
| TW202222347A (zh) | 2022-06-16 |
| SMT202500381T1 (it) | 2025-11-10 |
| EP4223295C0 (en) | 2025-07-30 |
| HUE073451T2 (hu) | 2026-01-28 |
| ES3041708T3 (en) | 2025-11-13 |
| JPWO2022071233A1 (pl) | 2022-04-07 |
| AU2021354445A1 (en) | 2023-05-18 |
| US20230372315A1 (en) | 2023-11-23 |
| PE20240109A1 (es) | 2024-01-22 |
| WO2022071233A1 (ja) | 2022-04-07 |
| TWI911294B (zh) | 2026-01-11 |
| CA3194011A1 (en) | 2022-04-07 |
| CN116472032A (zh) | 2023-07-21 |
| EP4223295A4 (en) | 2024-08-28 |
| EP4223295B1 (en) | 2025-07-30 |
| BR112023005756A2 (pt) | 2023-05-09 |
| ZA202303906B (en) | 2024-06-26 |
| ECSP23020965A (es) | 2023-04-28 |
| KR20230084205A (ko) | 2023-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3881846A4 (en) | PHARMACEUTICAL COMPOSITION WITH PARP INHIBITORS | |
| GB202019241D0 (en) | Pharmaceutical composition | |
| EP3675802A4 (en) | COMPOSITIONS AND MEDICAL DEVICES WITH ANTIMICROBACTERIAL PARTICLES | |
| SI3341024T1 (sl) | Tekoči farmacevtski sestavki, ki vsebujejo zaviralce SGLT-2 | |
| GB202002786D0 (en) | Liquid pharmaceutical composition | |
| ZA201907313B (en) | Stable liquid pharmaceutical composition | |
| GB2578093B (en) | Liquid pharmaceutical composition comprising RPL554 and HFA-134A | |
| IL300090A (en) | Pharmaceutical preparations containing VENGLUSTAT | |
| GB202010230D0 (en) | Pharmaceutical formulation | |
| PL4223295T3 (pl) | Płynna kompozycja farmaceutyczna wykazująca doskonałą skuteczność konserwującą | |
| GB202100526D0 (en) | Pharmaceutical formulation | |
| IL297081A (en) | Pharmaceutical formulation | |
| IL291380A (en) | A pharmaceutical preparation containing a peptide-tetrahydroisoquinoline conjugate of thrombus dissolution | |
| IL268329A (en) | A liquid preparation containing perdofloxacin | |
| PL4027974T3 (pl) | Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę | |
| GB202018068D0 (en) | Pharmaceutical composition | |
| GB202010340D0 (en) | Pharmaceutical composition | |
| ZA202001892B (en) | Combined pharmaceutical formulation comprising dapagliflozin l-proline and metformin | |
| GB202116644D0 (en) | Liquid composition | |
| GB202012897D0 (en) | Pharmaceutical compositions comprising ionic liquids | |
| GB202101634D0 (en) | Pharmaceutical composition | |
| GB202101638D0 (en) | Pharmaceutical composition | |
| GB202100711D0 (en) | Pharmaceutical composition | |
| PL3841878T3 (pl) | Ciekła kompozycja pestycydowa | |
| GB202019237D0 (en) | Pharmaceutical composition |